[Skip to Content]

Upstate Active Clinical Trials

Study Title:

AALL1631 - International Phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones

What is the purpose of the study? (in Layman's terms, please describe the study)

trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones

Upstate Institutional Review Board (IRB) Number:

1111949

Study/Protocol ID:

AALL1631

Study Phase:

III

Patient Age Group:

Children

Principal Investigator:

Melanie A Comito

Who is eligible?

≥ 1 year (365 days) and ≤ 21 years at ALL diagnosis

What is involved if I participate?

  • How long is the study?
    until accrual is met
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    Yes
  • What tests and procedures are involved?
    lab draws, lumbar punctures, bone marrow biopsy/aspirate

Where will the study take place?

SUNY Upstate Medical University

Other Information:

N/A

Who can I contact for more information?

Name: Karen B Bilynsky
Phone: 315-464-7601
Email: [email protected]

Return to Previous Page || Search Again

Top